Proactive Investors Interview – Algernon Pharmaceuticals files a pre-IND meeting request with US FDA for Ifenprodil Small Cell Lung Cancer Study

Proactive Investors Interview – Algernon Pharmaceuticals files a pre-IND meeting request with US FDA for Ifenprodil Small Cell Lung Cancer Study

 

Share via
Copy link
Powered by Social Snap